Changes in Beneficial Ownership · 4
Foghorn Therapeutics Inc.
FHTXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
primarydocument.xml
Filing details
- Report period
- 2026-06-24
- Issuer
- Foghorn Therapeutics Inc.
- Issuer CIK
- 0001822462
- Trading symbol
- FHTX
Reporting owner 1
- Name
- SMITH IAN F
- Reporting owner CIK
- 0001197032
- Relationship
- Director
- Address
- 99 COOLIDGE AVENUE, STE 500, WATERTOWN, MA, 02742
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) | 4.08 | 2026-06-24 | A · Form 4 | 28,000.00 | A | 4.08 | [F1] | 2036-06-23 | Common Stock | 28,000.00 | 28,000.00 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors.↩ 1
Signature 1
- Signed
- /s/ Michael LaCascia, Attorney-in-Fact for Ian F. Smith
- Date
- 2026-06-25
Filed exhibits
- SECTION 16 POA- SMITH 2024 ↗smithex24.txt
Recent company filings
- 3 filingOct 5, 2026
- SCHEDULE 13G/A - filed by BIOTECHNOLOGY VALUE FUND L P regarding Foghorn Therapeutics Inc.Oct 5, 2026
- Costs Associated with Exit or Disposal Activities · Regulation FD DisclosureOct 1, 2026
- 10-Q filingAug 6, 2026
- Results of Operations and Financial Condition · Regulation FD DisclosureAug 6, 2026